Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | ALB | P02768 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | HNF4A | P41235 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.47 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2960122 | 0.83 | ALDH1A1 (0.57) | POLBALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL110532 | 0.81 | ALDH1A1 (0.70) | POLBALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL144989 | 0.79 | POLB (1.00) | POLBALDH1A1KDM4EHPGDALOX15 | |
| SCHEMBL29380162 | 0.79 | POLB (1.00) | POLBALDH1A1KDM4EHPGDALOX15 | |
| SCHEMBL9755026 | 0.79 | HPGD (0.52) | POLBALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL27051667 | 0.79 | ALB (0.52) | POLBALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL5832438 | 0.79 | POLB (0.46) | POLBALDH1A1KDM4EHPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL28210457 | 0.79 | ALDH1A1 (0.67) | POLBALDH1A1KDM4EHPGDHSD17B10 | |
| Methane SCHEMBL28154128 | 0.79 | ALDH1A1 (0.67) | POLBALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL28094410 | 0.79 | ALDH1A1 (0.67) | POLBALDH1A1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012169077-A1 | PROCESS FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2012-12-13 | — | — | WO | claimed |
| JP-9228081-A | — | — | None | — | — | JP | disclosed |
| US-20140366905-A1 | PROCESS FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2014-12-18 | — | — | US | disclosed |
| EP-2806850-A1 | PROCESS FOR TREATING KERATIN FIBERS | L'Oréal (FR) | 2014-12-03 | — | — | EP | disclosed |
| WO-2013111346-A1 | PROCESS FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2013-08-01 | — | — | WO | disclosed |
| WO-2012169077-A1 | PROCESS FOR TREATING KERATIN FIBERS | L'OREAL (FR) | 2012-12-13 | — | — | WO | disclosed |
| US-20120058254-A1 | ELECTROLESS PLATING SOLUTION, METHOD FOR ELECTROLESS PLATING USING THE SAME AND METHOD FOR MANUFACTURING CIRCUIT BOARD | C. UYEMURA & CO., LTD. (JP) | 2012-03-08 | — | — | US | disclosed |
| US-7569318-B2 | double hydroxide salt contains monovalent and/or divalent, and also trivalent, metal cations (Mg, Ca, Zn, Co, Ni, Fe, Cu and Mn) and an aromatic acid (benzoic acid, naphthoic acid, 4-tert-butylbenzoic acid, benzenesulfonic acid, naphthalenesulfonic acid); influence electrostatic charging in a matrix | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-08-04 | — | — | US | disclosed |
| US-20060020069-A1 | Use of salts of layered double hydoxides | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2006-01-26 | — | — | US | disclosed |
| JP-H09228081-A | PICKLING SOLUTION FOR STAINLESS STEEL AND METHOD FOR PICKLING STAINLESS STEEL USING THE SOLUTION | KAWASAKI STEEL CORP | 1997-09-02 | — | — | JP | disclosed |
| US-4141734-A | SUBSTITUTED ORGANIC DI- OR TRISULFIDE ANTIDEPOSIT AGENTS | CIBA-GEIBY AG (CH) | 1979-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140366905-A1 | PROCESS FOR TREATING KERATIN FIBERS | KRT18, CKAP4, HSPA4L | POLB 966/4885ALDH1A1 791/4885KDM4E 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.